Related Experiment Videos
Proton MR spectroscopy in Wernicke encephalopathy
Carlos A Rugilo1, Marcela C Uribe Roca, Maria C Zurru
1Servicio de Neurología, Buenos Aires, Argentina.
AJNR. American Journal of Neuroradiology
|May 16, 2003
Summary
Wernicke encephalopathy, a condition from thiamine deficiency, is often difficult to diagnose clinically. Advanced MR imaging and spectroscopy can aid in its early detection by revealing characteristic findings like increased lactate.
Area of Science:
- Neurology
- Radiology
- Biochemistry
Background:
- Wernicke encephalopathy results from thiamine (vitamin B1) deficiency.
- Clinical diagnosis of Wernicke encephalopathy is challenging, achieved in only 20% of cases.
- Early and accurate diagnosis is crucial for effective treatment and preventing neurological damage.
Observation:
- This report details MR imaging and proton MR spectroscopic findings in a patient with Wernicke encephalopathy.
- The patient presented with clinical and biochemical features consistent with the condition.
- Specific MR imaging abnormalities and elevated lactate levels were observed.
Findings:
- MR imaging revealed characteristic changes in the brain consistent with Wernicke encephalopathy.
- Proton MR spectroscopy demonstrated increased lactate levels in affected brain regions.
- These findings correlate with the known pathophysiology of thiamine deficiency.
Implications:
- Advanced MR imaging and spectroscopy can significantly improve the early diagnosis of Wernicke encephalopathy.
- Identifying specific biomarkers like lactate aids in confirming the diagnosis.
- Enhanced diagnostic capabilities can lead to timely intervention and better patient outcomes.